Kinaxis Inc. (TSE:KXS – Get Free Report) Director Angel Luis Mendez sold 6,100 shares of the business’s stock in a transaction dated Thursday, August 28th. The stock was sold at an average price of C$190.00, for a total value of C$1,159,000.00. Following the completion of the sale, the director owned 1,400 shares in the company, valued at C$266,000. This represents a 81.33% decrease in their ownership of the stock.
Kinaxis Stock Down 0.3%
TSE KXS opened at C$189.65 on Wednesday. The stock has a 50 day moving average price of C$197.74 and a 200-day moving average price of C$185.89. Kinaxis Inc. has a one year low of C$149.62 and a one year high of C$212.45. The company has a market capitalization of C$5.36 billion, a P/E ratio of 220.52, a P/E/G ratio of 3.60 and a beta of 0.93. The company has a debt-to-equity ratio of 12.12, a quick ratio of 2.29 and a current ratio of 1.89.
Wall Street Analyst Weigh In
A number of research analysts recently commented on the stock. Royal Bank Of Canada increased their price target on shares of Kinaxis from C$225.00 to C$235.00 in a report on Friday, August 8th. Scotiabank upped their price objective on Kinaxis from C$225.00 to C$240.00 and gave the company an “outperform” rating in a research report on Friday, August 8th. Finally, Stifel Nicolaus raised their price objective on Kinaxis from C$225.00 to C$245.00 and gave the company a “buy” rating in a research note on Thursday, July 31st. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Kinaxis has a consensus rating of “Moderate Buy” and an average target price of C$216.43.
About Kinaxis
Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm’s flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation.
Featured Articles
- Five stocks we like better than Kinaxis
- Following Congress Stock Trades
- Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
- Using the MarketBeat Dividend Yield Calculator
- 3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- The Quiet Before the Catalyst: Vertical Aerospace’s Next Move
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
